S
Stanley Nattel
Researcher at Montreal Heart Institute
Publications - 802
Citations - 72437
Stanley Nattel is an academic researcher from Montreal Heart Institute. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 132, co-authored 778 publications receiving 65700 citations. Previous affiliations of Stanley Nattel include Mayo Clinic & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Drug Shortages: Patients and Health Care Providers Are All Drawing the Short Straw
François Rinaldi,Simon de Denus,Simon de Denus,Angela Nguyen,Stanley Nattel,Stanley Nattel,Jean-François Bussières +6 more
TL;DR: If drug shortages are here to stay, clinicians, drug manufacturers, and relevant organizations should work together to increase accountability for drug availability and adaptation to shortages, and to create more effective tools with which to anticipate and respond to critical supply fluctuations.
Journal ArticleDOI
Differential Interactions of Na+ Channel Toxins with T-type Ca2+ Channels
Hui Sun,Diego Varela,Denis Chartier,Peter C. Ruben,Stanley Nattel,Gerald W. Zamponi,Normand Leblanc +6 more
TL;DR: The nature of low-threshold ICa in dog atrium is reexamined, as well as whether it is affected by Na+ channel toxins, to extend the hypothesis of a parallel evolution of Na+ and Ca2+ channels from an ancestor with common structural motifs.
Proceedings ArticleDOI
Interactions between cardiac fibrosis spatial pattern and ionic remodeling on electrical wave propagation
Philippe Comtois,Stanley Nattel +1 more
TL;DR: It is found that the propagation failure is highly dependent on the spatial pattern of fibrosis for all conditions studied with maximum sensitivity for patterns with combination of small and large clusters, but the effect is particularly sensitive to reduced sodium current condition where conduction block occurred at lower fibrosis density.
Journal ArticleDOI
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.
Stanley Nattel,Philip T. Sager,Jörg Hüser,Jordi Heijman,Jordi Heijman,Dobromir Dobrev,Dobromir Dobrev,Dobromir Dobrev +7 more
TL;DR: In this paper, the authors focus on rhythm control therapy and explore the challenges that underlie this phenomenon, including regulatory hurdles and considerations and then review industry concerns and strategies, and suggest possible paths for the future.
Journal ArticleDOI
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications
Monika Gawałko,T. Agbaedeng,Arnela Saljic,Dominik N. Müller,Nicola Wilck,Renate Schnabel,John Penders,Michiel Rienstra,Isabelle C. Van Gelder,Thomas Jespersen,Ulrich Schotten,Harry J.G.M. Crijns,Jonathan M. Kalman,Prashanthan Sanders,Stanley Nattel,Dobromir Dobrev,Dobromir Dobrev,Dobromir Dobrev,Dominik Linz +18 more
TL;DR: In this paper, the authors discuss the evidence suggesting a potential bidirectional association between atrial fibrillation and gut microbiota, identifying gut microbiota-derived metabolites as possible regulators of the AF substrate.